Molecular Mechanisms Underlying the Regulation of Local Chromatin Structure
局部染色质结构调控的分子机制
基本信息
- 批准号:10661627
- 负责人:
- 金额:$ 38.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Antifungal AgentsAntineoplastic AgentsBiochemistryBiological AssayBiological ProcessCellsChromatinChromatin StructureComplex AnalysisDNADNA RepairDNA SequenceDNA biosynthesisDeuteriumDevelopmentDiseaseEP300 geneGene Expression ProfileGenetic TranscriptionGenomic DNAHMGN ProteinsHistone H1HistonesHumanHydrogenMalignant NeoplasmsMolecularMolecular ChaperonesNucleosomesPathogenicityPlayPost-Translational Protein ProcessingRegulationResearchResolutionRoleSystemTherapeuticVariantWorkYeastsanticancer treatmenthigh throughput screeninghistone acetyltransferasehistone modificationin vivointerestnovelpublic health relevancetranslational impacttranslational study
项目摘要
PROPOSAL SUMMARY
The packaging of genomic DNA into repeating nucleosome units plays a pivotal role in the regulation of
essential biological process including DNA transcription, DNA replication, and DNA repair. Cells must assemble
and disassemble nucleosomes to read the information stored in the DNA sequence in a temporally and spatially
regulated way. As such, cells have evolved several mechanisms that precisely regulate nucleosome dynamics
and influence the local structure of chromatin. These mechanisms include: (1) the incorporation of histone
variants into the nucleosome, (2) post-translational modification of histones, (3) histone chaperone activity, (4)
ATP-dependent nucleosome remodeling, and (5) nucleosome-binding proteins. We currently do not know how
these mechanisms act synergistically, nor how they influence intrinsic nucleosome dynamics.
The research proposed in this MIRA application will focus on the quantification of nucleosome dynamics
and the molecular basis of its regulation. We will develop a high-throughput assay for the quantification of
nucleosome dynamics that will be applied to nucleosome assembly intermediates, mono-nucleosomes and multi-
nucleosome arrays. This assay revolves around hydrogen-deuterium exchange analysis chromatin substrates
in varied biologically-relevant states. We will also characterize the molecular mechanisms underpinning
concerted activity of histone chaperones and histone acetyltransferases. Systems of interest at Rtt109, Vps75
and Asf1; as well as Nap1, CBP/p300 and linker histone H1. Varied approaches will be employed including
biochemistry, high-resolution structural characterization, and in vivo complex analysis. The proposed work will
impact translational studies motivated to develop anti-fungal therapeutics and identify new avenues for targeting
of anti-cancer treatments.
建议书摘要
基因组DNA包装成重复的核小体单位在调节
基本的生物学过程,包括DNA转录、DNA复制和DNA修复。细胞必须组装在一起
以及分解核小体以在时间和空间上读取存储在DNA序列中的信息
规范的方式。因此,细胞进化出几种精确调节核小体动态的机制。
并影响染色质的局部结构。这些机制包括:(1)组蛋白的掺入
变异体进入核小体,(2)组蛋白翻译后修饰,(3)组蛋白伴侣活性,(4)
依赖于ATP的核小体重塑,以及(5)核小体结合蛋白。我们目前还不知道如何
这些机制是协同作用的,也不知道它们如何影响内在的核小体动力学。
在这个Mira应用中提出的研究将集中在核小体动力学的量化上
以及其调控的分子基础。我们将开发一种高通量的定量分析方法
核小体动力学将应用于核小体组装中间体、单核小体和多核小体。
核小体阵列。这项分析围绕着氢-重离子交换分析染色质底物。
在不同的生物相关状态下。我们还将描述支撑分子机制的特征。
组蛋白伴侣和组蛋白乙酰转移酶的协同活性。感兴趣的系统在Rtt109,Vps75
和ASF1,以及NAP1、CBP/p300和连接子组蛋白H1。我们会采用不同的方法,包括
生物化学、高分辨率结构表征和体内络合物分析。拟议的工作将
旨在开发抗真菌治疗药物和确定靶向的新途径的IMPACT翻译研究
抗癌治疗。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HD-eXplosion: visualization of hydrogen-deuterium exchange data as chiclet and volcano plots with statistical filtering.
HD-eXplosion:通过统计过滤将氢-氘交换数据可视化为巧克力图和火山图。
- DOI:10.1093/bioinformatics/btaa892
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Zhang,Naifu;Yu,Xiaohe;Zhang,Xinchao;D'Arcy,Sheena
- 通讯作者:D'Arcy,Sheena
Using hydrogen-deuterium exchange mass spectrometry to characterize Mtr4 interactions with RNA.
- DOI:10.1016/bs.mie.2022.04.002
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Leveraging intrinsic flexibility to engineer enhanced enzyme catalytic activity.
- DOI:10.1073/pnas.2118979119
- 发表时间:2022-06-07
- 期刊:
- 影响因子:11.1
- 作者:
- 通讯作者:
Comprehensive analysis of histone-binding proteins with multi-angle light scattering.
通过多角度光散射对组蛋白结合蛋白进行综合分析。
- DOI:10.1016/j.ymeth.2020.01.014
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Sarkar,Prithwijit;Akhavantabib,Noushin;D'Arcy,Sheena
- 通讯作者:D'Arcy,Sheena
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheena D'Arcy其他文献
Sheena D'Arcy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheena D'Arcy', 18)}}的其他基金
Molecular Mechanisms Underlying the Regulation of Local Chromatin Structure
局部染色质结构调控的分子机制
- 批准号:
10430063 - 财政年份:2019
- 资助金额:
$ 38.25万 - 项目类别:
Molecular Mechanisms Underlying the Regulation of Local Chromatin Structure
局部染色质结构调控的分子机制
- 批准号:
10201668 - 财政年份:2019
- 资助金额:
$ 38.25万 - 项目类别:
Molecular Mechanisms Underlying the Regulation of Local Chromatin Structure
局部染色质结构调控的分子机制
- 批准号:
10004691 - 财政年份:2019
- 资助金额:
$ 38.25万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 38.25万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 38.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 38.25万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 38.25万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 38.25万 - 项目类别: